- Home
- PMVP vs ME Comparison
PMVP vs ME Comparison
Compare PMVP & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- ME
- Stock Information
- Founded
- PMVP 2013
- ME 2006
- Country
- PMVP United States
- ME United States
- Employees
- PMVP N/A
- ME N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- ME Precision Instruments
- Sector
- PMVP Health Care
- ME Health Care
- Exchange
- PMVP Nasdaq
- ME Nasdaq
- Market Cap
- PMVP 85.5M
- ME 98.7M
- IPO Year
- PMVP 2020
- ME N/A
- Fundamental
- Price
- PMVP $1.37
- ME $3.61
- Analyst Decision
- PMVP Strong Buy
- ME Hold
- Analyst Count
- PMVP 3
- ME 1
- Target Price
- PMVP $5.33
- ME $9.40
- AVG Volume (30 Days)
- PMVP 175.1K
- ME 234.3K
- Earning Date
- PMVP 02-27-2025
- ME 02-05-2025
- Dividend Yield
- PMVP N/A
- ME N/A
- EPS Growth
- PMVP N/A
- ME N/A
- EPS
- PMVP N/A
- ME N/A
- Revenue
- PMVP N/A
- ME $193,260,000.00
- Revenue This Year
- PMVP N/A
- ME $21.93
- Revenue Next Year
- PMVP N/A
- ME $17.31
- P/E Ratio
- PMVP N/A
- ME N/A
- Revenue Growth
- PMVP N/A
- ME N/A
- 52 Week Low
- PMVP $1.32
- ME $2.66
- 52 Week High
- PMVP $2.26
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- PMVP 33.56
- ME 50.49
- Support Level
- PMVP $1.32
- ME $3.34
- Resistance Level
- PMVP $1.50
- ME $4.18
- Average True Range (ATR)
- PMVP 0.07
- ME 0.30
- MACD
- PMVP -0.01
- ME 0.02
- Stochastic Oscillator
- PMVP 16.61
- ME 48.65
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.